Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Development and validation of a cardiovascular risk prediction model in type 1 diabetes

Open access
McGurnaghan, Stuart J., McKeigue, Paul M., Read, Stephanie H., Franzen, Stefan, Svensson, Ann-Marie, Colombo, Marco, Livingstone, Shona, Farran, Bassam, Caparrotta, Thomas M., Blackbourn, Luke A. K., Mellor, Joseph, Thoma, Ioanna, Sattar, Naveed, Wild, Sarah H., Gudbjörnsdottir, Soffia, Colhoun, Helen M., on behalf of the Swedish National Diabetes Register and the Scottish Diabetes Research Network Epidemiology Group · 2021 · Diabetologia

Abstract

Aims/hypothesis: We aimed to report current rates of CVD in type 1 diabetes and to develop a CVD risk prediction tool for type 1 diabetes. Methods: A cohort of 27,527 people with type 1 diabetes without prior CVD was derived from the national register in Scotland. Incident CVD events during 199,552 person-years of follow-up were ascertained using hospital admissions and death registers. A Poisson regression model of CVD was developed and then validated in the Swedish National Diabetes Register (n = 33,183). We compared the percentage with a high 10 year CVD risk (i.e., ≥10%) using the model with the percentage eligible for statins using current guidelines by age. Results: The age-standardised rate of CVD per 100,000 person-years was 4070 and 3429 in men and women, respectively, with type 1 diabetes in Scotland, and 4014 and 3956 in men and women in Sweden. The final model was well calibrated (Hosmer–Lemeshow test p > 0.05) and included a further 22 terms over a base model of age, sex and diabetes duration (C statistic 0.82; 95% CI 0.81, 0.83). The model increased the base model C statistic from 0.66 to 0.80, from 0.60 to 0.75 and from 0.62 to 0.68 in those aged <40, 40–59 and ≥ 60 years, respectively (all p values <0.005). The model required minimal calibration in Sweden and had a C statistic of 0.85. Under current guidelines, >90% of those aged 20–39 years and 100% of those≥40 years with type 1 diabetes were eligible for statins, but it was not until age 65 upwards that 100% had a modelled risk of CVD≥10% in 10 years. Conclusions/interpretation: A prediction tool such as that developed here can provide individualised risk predictions. This 10 year CVD risk prediction tool could facilitate patient discussions regarding appropriate statin prescribing. Apart from 10 year risk, such discussions may also consider longer-term CVD risk, the potential for greater benefits from early vs later statin intervention, the potential impact on quality of life of an early CVD event and evidence on safety, all of which could influence treatment decisions, particularly in younger people with type 1 diabetes. Graphical abstract:

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-021-05478-4

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 (a–f) Calibration of the model in the Scottish cross-validation test dataset overall and by sex and age band. (a) All (199,552 person-years). (b) Female (86,131 person-years). (c) Male (113,421 person-years). (d) Age at entry 20–39 years (89,089 person-years). (e) Age at entry 40–59 years (73,005 person-years). (f) Age at entry ≥60 years (11,197 person-years)
Fig. 1 (a–f) Calibration of the model in the Scottish cross-validation test dataset overall and by sex and age band. (a) All (199,552 person-years). (b) Female (86,131 person-years). (c) Male (113,421 person-years). (d) Age at entry 20–39 years (89,089 person-years). (e) Age at entry 40–59 years (73,005 person-years). (f) Age at entry ≥60 years (11,197 person-years)CC BY · PubMed Central
Fig. 2 Probability of surviving without CVD, conditional on not being censored by non-CVD death, based on age- and sex-specific averaged survival probabilities from the model
Fig. 2 Probability of surviving without CVD, conditional on not being censored by non-CVD death, based on age- and sex-specific averaged survival probabilities from the modelCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 54

Metadata

Authors
McGurnaghan, S. J., McKeigue, P. M., Read, S. H., Franzen, S., Svensson, A.-M., Colombo, M., Livingstone, S., Farran, B., Caparrotta, T. M., Blackbourn, L. A. K., Mellor, J., Thoma, I., Sattar, N., Wild, S. H., Gudbjörnsdottir, S., Colhoun, H. M., & on behalf of the Swedish National Diabetes Register and the Scottish Diabetes Research Network Epidemiology Group
Affiliations
  • Institute of Genetics and Cancer (GB)
  • University of Edinburgh (GB)
  • Women's College Hospital (CA)
  • Sahlgrenska University Hospital (SE)
  • University of Dundee (GB)
  • University of Glasgow (GB)
  • NHS Fife (GB)
Corresponding author
  • McGurnaghan, Stuart J.
  • Colhoun, Helen M.
Venue
Diabetologia
Published
2021-06-09
Volume
64
Issue
9
Pages
2001-2011
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W3172852952
Cited by
53
References
23
Citations by year
2026: 11 · 2025: 10 · 2024: 13 · 2023: 9 · 2022: 8 · 2021: 2
FWCI
6.15
Type
journal article
Language
en
Open access
Licence
Locations
  • Diabetologia (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • Discovery Research Portal (University of Dundee) (submittedVersion, cc-by)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
Funders
Chief Scientist Office (ETM/47)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
type 1 diabetes, cardiovascular disease, cardiovascular risk prediction models, statin eligibility, statin prescribing, diabetes duration, sex differences, Scotland, Sweden, model validation, calibration, hypercholesterolemia, dyslipidemia, smoking
MeSH terms
Heart Disease Risk Factors, Adult, Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Female, Humans, Male, Middle Aged, Quality of Life, Risk Factors, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Development and validation of a cardiovascular risk prediction model in type 1 diabetes. https://app.cochat.ai/papers/10.1007/s00125-021-05478-4
The paper
McGurnaghan, S. J., McKeigue, P. M., Read, S. H., Franzen, S., Svensson, A.-M., Colombo, M., Livingstone, S., Farran, B., Caparrotta, T. M., Blackbourn, L. A. K., Mellor, J., Thoma, I., Sattar, N., Wild, S. H., Gudbjörnsdottir, S., Colhoun, H. M., & on behalf of the Swedish National Diabetes Register and the Scottish Diabetes Research Network Epidemiology Group. (2021). Development and validation of a cardiovascular risk prediction model in type 1 diabetes. Diabetologia. https://doi.org/10.1007/s00125-021-05478-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.